SS31 alleviates LPS-induced acute lung injury by inhibiting inflammatory responses through the S100A8/NLRP3/GSDMD signaling pathway

Peiyao Luo,Quankuan Gu,Jianpeng Wang,Xianyong Li,Nana Li,Wei Yang,Xianglin Meng,Mingyan Zhao
DOI: https://doi.org/10.1186/s40001-024-02169-9
IF: 4.981
2024-11-30
European Journal of Medical Research
Abstract:Acute lung injury/acute respiratory distress syndrome (ALI/ARDS) is an acute, diffuse, inflammatory lung injury caused by various endogenous or exogenous factors. It is currently widely recognized that an excessive inflammatory response resulting from immune imbalance constitutes a crucial pathogenic mechanism in ALI/ARDS. SS31 is a novel mitochondria-targeted antioxidant peptide. This article validates the role of SS31 in lipopolysaccharide (LPS)-induced ALI.
medicine, research & experimental
What problem does this paper attempt to address?